EVs have been reported to contain AD-related molecules including Aβ (Jia et al., 2019) and Tau proteins (Wang et al., 2017), and to facilitate the spreading of these pathogenic molecules in the brain (Dinkins et al., 2014; Asai et al., 2015). Here, MAPT is linked to Alzheimer disease.